Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Overview of attention for article published in Frontiers in oncology, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 59,038 followers.

RT @UCCancerCenter: Drs. Funmi Olopade and James Dignam lead this new international study: Efficacy of Anti-HER2 Agents in Combination With…

RT @UCCancerCenter: Drs. Funmi Olopade and James Dignam lead this new international study: Efficacy of Anti-HER2 Agents in Combination With…

RT @UCCancerCenter: Drs. Funmi Olopade and James Dignam lead this new international study: Efficacy of Anti-HER2 Agents in Combination With…

RT @UCCancerCenter: Drs. Funmi Olopade and James Dignam lead this new international study: Efficacy of Anti-HER2 Agents in Combination With…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.